Immunoexpression of CXCL12 and CXCR4 in oral tongue squamous cell carcinoma of young and older patients
European Archives of Oto-Rhino-Laryngology · 2025
DOI: 10.1007/s00405-024-09106-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Daniella de Lucena Morais und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, State University of Paraíba, Campina Grande, PB, Brazil. Hauptthemen laut MEDLINE: Receptors, CXCR4, Chemokine CXCL12, Tongue Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
PURPOSE: This study analyzed the immunoexpression of C-X-C chemokine ligand 12 (CXCL12) and C-X-C chemokine receptor 4 (CXCR4) in oral tongue squamous cell carcinoma (OTSCC) of young (≤ 45 years) and older (≥ 60 years) patients and correlated the findings with clinicopathological parameters (sex, tumor size, regional metastasis, clinical stage, and histopathological grade of malignancy). METHODS: Forty OTSCC cases (20 diagnosed in young patients and 20 diagnosed in older patients) were selected. Cytoplasmic (CXCL12 and CXCR4) and nuclear (CXCR4) staining percentages in epithelial and stromal cells were assessed at the invasive tumor front. RESULTS: Low median percentages of CXCL12 positivity were observed in epithelial and stromal cells of OTSCC in both age groups. In stromal cells, expression of this chemokine was higher in older individuals compared to young individuals (p = 0.026). Expression of CXCR4 in neoplastic cells was more frequent in older individuals, with higher median percentages of cytoplasmic (p = 0.023) and nuclear (p = 0.001) positivity compared to young individuals. In stromal cells, older individuals exhibited a significantly higher cytoplasmic expression of CXCR4 (p 0.05). Positive correlations between cytoplasmic and nuclear expressions of CXCR4 were found in young (r = 0.580; p = 0.007) and older individuals (r = 0.476;p = 0.034). CONCLUSION: The results suggest the participation of CXCR4 in the development of OTSCC, especially in older individuals. The findings also support possible age-related differences in the pathogenesis of this malignant neoplasm. Nevertheless, this protein may not be involved in the progression of OTSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, State University of Paraíba, Campina Grande, PB, Brazil.
- Department of Biological and Health Sciences, Federal University of Western Bahia, Barreiras, BA, Brazil.
- Department of Stomatology (Oral Pathology), Federal University of Goiás, Goiânia, GO, Brazil.
- Department of Dentistry, State University of Paraíba, Campina Grande, PB, Brazil. cfwnonaka@gmail.com.
- Departamento de Odontologia, Universidade Estadual da Paraíba, Programa de Pós-Graduação em Odontologia, Rua Baraúnas, 351- Bairro Universitário, Campina Grande , PB, CEP 58429-500, Brasil. cfwnonaka@gmail.com.
Förderung
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
de Lucena Morais, D., de Sena, L. S. B., Silva Cunha, J. L., de Mendonça, E. F., Alves, P. M., & Nonaka, C. F. W. (2025). Immunoexpression of CXCL12 and CXCR4 in oral tongue squamous cell carcinoma of young and older patients. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09106-w
Vancouver
de Lucena Morais D, de Sena LSB, Silva Cunha JL, de Mendonça EF, Alves PM, Nonaka CFW. Immunoexpression of CXCL12 and CXCR4 in oral tongue squamous cell carcinoma of young and older patients. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09106-w
BibTeX
@article{deLucenaMorais2025,
author = {de Lucena Morais, Daniella and de Sena, Luana Samara Balduíno and Silva Cunha, John Lennon and de Mendonça, Elismauro Francisco and Alves, Pollianna Muniz and Nonaka, Cassiano Francisco Weege},
title = {Immunoexpression of CXCL12 and CXCR4 in oral tongue squamous cell carcinoma of young and older patients},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2025},
doi = {10.1007/s00405-024-09106-w}
}
EUVIMED